Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2025-11-04 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Posting of Circular and Notice of General Meeting
Regulatory Filings Classification · 1% confidence The document is an announcement from ValiRx PLC regarding a fundraising activity, including the posting of a circular and notice of a general meeting. It details the number of shares to be issued, the use of proceeds, and an expected timetable for the fundraising events. While it mentions a circular, the document itself is a regulatory announcement (RNS) detailing the capital raise and the upcoming meeting, which fits the 'Capital/Financing Update' category as it provides specific details on the fundraising structure, proceeds, and share issuance.
2025-11-04 English
Result of WRAP Retail Offer
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from ValiRx PLC regarding the results of a 'WRAP Retail Offer' and the issuance of new ordinary shares. It details the gross proceeds raised, the number of shares issued, and the anticipated admission of these shares to trading on the AIM market. This falls under the category of capital changes and share issuance announcements. According to the provided definitions, 'SHA' (Share Issue/Capital Change) is the most accurate classification for announcements regarding new share issues and capital structure changes.
2025-11-04 English
WRAP Retail Offer for up to £300,000
Capital/Financing Update Classification · 1% confidence The document is an announcement from ValiRx PLC regarding a 'WRAP Retail Offer' to raise capital through the issuance of new ordinary shares and warrants. It details the offer price, the purpose of the funds, the eligibility of investors, and the timeline for the offer. This falls under the category of capital raising and financing activities. According to the provided definitions, 'CAP' (Capital/Financing Update) is the most appropriate classification for updates on company fundraising and financing activities.
2025-10-30 English
Fundraising of up to £1,050,000
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from ValiRx PLC regarding a fundraising initiative involving a placing, a retail offer, and share subscriptions. It details the number of shares, issue price, use of proceeds, and the regulatory context (UK MAR). Since this is a primary announcement of a capital raise and share issuance, it falls under the 'Share Issue/Capital Change' category.
2025-10-30 English
Inaphaea Commercial update
Regulatory Filings Classification · 1% confidence The document is a corporate announcement from ValiRx PLC regarding commercial updates for its subsidiary, Inaphaea. It details business developments, partnerships, and operational progress. It is distributed via the London Stock Exchange's RNS (Regulatory News Service) and does not fit into specific categories like financial reports, dividend notices, or director dealings. Therefore, it is classified as a general regulatory filing.
2025-10-14 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half Yearly Report' for ValiRx PLC for the period ended 30 June 2025. It contains comprehensive financial highlights, operational updates, and a Chairman/CEO statement. It is a substantive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.